Evidence map›Paper›PMID 39728927›Full record

ArticleeLife2024

Passive accumulation of alkaloids in inconspicuously colored frogs refines the evolutionary paradigm of acquired chemical defenses.

Rebecca D Tarvin, Jeffrey L Coleman, David A Donoso, Mileidy Betancourth-Cundar, Karem López-Hervas, Kimberly S Gleason, J Ryan Sanders, Jacqueline M Smith, Santiago R Ron, Juan C Santos and 3 more

Abstract read
In one paragraph

Article in eLife, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Genome size evolution and phenotypic correlates in the poison frog family Dendrobatidae.Evolution; international journal of organic evolution · 2025
    Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Rebecca D TarvinMuseum of Vertebrate Zoology and Department of Integrative Biology, University of California, Berkeley, Berkeley, United States.ORCID https://orcid.org/0000-0001-5387-7250
Jeffrey L ColemanDepartment of Integrative Biology and Biodiversity Collections, University of Texas at Austin, Austin, United States.ORCID https://orcid.org/0000-0002-8156-5948
David A DonosoGrupo de Investigación en Ecología Evolutiva en los Trópicos (EETROP), Universidad de las Américas, Quito, Ecuador.ORCID https://orcid.org/0000-0002-3408-1457
Mileidy Betancourth-CundarDepartamento de Ciencias Biológicas, Universidad de los Andes, Bogotá, Colombia.ORCID https://orcid.org/0000-0003-2368-6028
Karem López-HervasMax Planck Institute for Evolutionary Biology, Plön, Germany.ORCID https://orcid.org/0000-0002-8296-377X
Kimberly S GleasonDepartment of Chemistry and Physics, Indiana State University, Terre Haute, United States.
J Ryan SandersDepartment of Chemistry and Physics, Indiana State University, Terre Haute, United States.
Jacqueline M SmithDepartment of Chemistry and Physics, Indiana State University, Terre Haute, United States.
Santiago R RonMuseo de Zoología, Escuela de Biología, Facultad de Ciencias Exactas y Naturales, Pontificia Universidad Católica del Ecuador, Quito, Ecuador.
Juan C SantosDepartment of Biological Sciences, St John's University, New York, United States.
Brian E SedioDepartment of Integrative Biology and Biodiversity Collections, University of Texas at Austin, Austin, United States.ORCID https://orcid.org/0000-0002-1723-9822
David C CannatellaDepartment of Integrative Biology and Biodiversity Collections, University of Texas at Austin, Austin, United States.
Richard W FitchDepartment of Chemistry and Physics, Indiana State University, Terre Haute, United States.ORCID https://orcid.org/0000-0002-4927-725X

Funding

Evolutionary genetics of adaptation to toxins in animalsR35GM150574 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI Rebecca D. Tarvin · 2023 to 2026
$1.6M
National Geographic Society #9468-14National Science Foundation CHE-1531972National Science Foundation DBI-1556967National Science Foundation DUE-0942345National Science Foundation IOS-1556982NIGMS NIH HHS R35 GM150574NIGMS NIH HHS R35GM150574The University of Texas at Austin SWG-22-01
6 · The paper itself

Abstract

Understanding the origins of novel, complex phenotypes is a major goal in evolutionary biology. Poison frogs of the family Dendrobatidae have evolved the novel ability to acquire alkaloids from their diet for chemical defense at least three times. However, taxon sampling for alkaloids has been biased towards colorful species, without similar attention paid to inconspicuous ones that are often assumed to be undefended. As a result, our understanding of how chemical defense evolved in this group is incomplete. Here, we provide new data showing that, in contrast to previous studies, species from each undefended poison frog clade have measurable yet low amounts of alkaloids. We confirm that undefended dendrobatids regularly consume mites and ants, which are known sources of alkaloids. Thus, our data suggest that diet is insufficient to explain the defended phenotype. Our data support the existence of a phenotypic intermediate between toxin consumption and sequestration - passive accumulation - that differs from sequestration in that it involves no derived forms of transport and storage mechanisms yet results in low levels of toxin accumulation. We discuss the concept of passive accumulation and its potential role in the origin of chemical defenses in poison frogs and other toxin-sequestering organisms. In light of ideas from pharmacokinetics, we incorporate new and old data from poison frogs into an evolutionary model that could help explain the origins of acquired chemical defenses in animals and provide insight into the molecular processes that govern the fate of ingested toxins.

Indexed as

AlkaloidsAnuraBiological EvolutionAnimalsAntsMitesPhenotypeAlkaloidsadaptive landscapebioaccumulationecologyevolutionary biologynoveltytoxicokineticstoxin resistancetoxin sequestration

Identifiers

PMID39728927
PMCPMC11677230

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.